Abstract 4134384: Sotagliflozin, a Dual Inhibitor of Sodium-Glucose Transporters 1 and 2, Elicits Cardioprotective Effects Through Attenuation of Platelet Activation and ThrombosisLivia Stanger, Michael Holinstat, Adriana Yamaguchi et al.|Circulation|2024Cited by 1
SOTAGLIFLOZIN, A DUAL SGLT1/2 INHIBITOR, UNLIKE THE SELECTIVE SGLT2 INHIBITOR EMPAGLIFLOZIN, INHIBITS HUMAN PLATELET ACTIVATION AND IN VIVO THROMBUS FORMATIONLivia Stanger, Michael Holinstat, B. Pitt|Journal of the American College of Cardiology|2025Cited by 0